Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
99mTc-MIP-1404 SPECT/CT for detecting clinically significant prostate cancer
NCT02615067Phase 3Completed
- Sponsor
- Molecular Insights Pharmaceuticals
- Start
- Dec 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of trofolastat in prostate cancer (PCa), sponsored by Molecular Insights Pharmaceuticals. Started Dec 2015; status: completed.
02
Drugs
trofolastat
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT02615067.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02615067.